APP and obesity due to melanocortin 4 receptor deficiency: In this study, we demonstrate that Andro, a natural anti-diabetic compound known to enhance glucose metabolism in the brain (62), successfully mitigated obesity-linked alterations in glucose metabolism in the VAT of APP-PS1 mice.